Literature DB >> 7592113

Identification of enterohaemorrhagic Escherichia coli by means of their production of enterohaemolysin.

K A Bettelheim1.   

Abstract

With increasing interest in verocytotoxigenic Escherichia coli (VTEC) being associated with both human and animal infection, a simple system of rapidly identifying the majority of VTEC has been devised. This depends on the fact that most VTEC produce enterohaemolysin, which is rarely produced by non-VTEC. By employing two media, traditional sheep blood agar (SBA) and washed sheep blood agar supplemented with calcium (WSBA-Ca), enterohaemolysin-producing strains can be easily differentiated from other E. coli enabling most VTEC types, including ones belonging to serogroups other than O157, to be isolated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592113     DOI: 10.1111/j.1365-2672.1995.tb00932.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  14 in total

1.  Sensitive detection of Escherichia coli O157:H7 in food and water by immunomagnetic separation and solid-phase laser cytometry.

Authors:  B H Pyle; S C Broadaway; G A McFeters
Journal:  Appl Environ Microbiol       Date:  1999-05       Impact factor: 4.792

2.  Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli.

Authors:  T J Novicki; J A Daly; S L Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Virulence properties and serotypes of Shiga toxin-producing Escherichia coli from healthy Australian slaughter-age sheep.

Authors:  S P Djordjevic; M A Hornitzky; G Bailey; P Gill; B Vanselow; K Walker; K A Bettelheim
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Seasonal Prevalence of Shiga Toxin-Producing Escherichia coli on Pork Carcasses for Three Steps of the Harvest Process at Two Commercial Processing Plants in the United States.

Authors:  Ivan Nastasijevic; John W Schmidt; Marija Boskovic; Milica Glisic; Norasak Kalchayanand; Steven D Shackelford; Tommy L Wheeler; Mohammad Koohmaraie; Joseph M Bosilevac
Journal:  Appl Environ Microbiol       Date:  2020-12-17       Impact factor: 4.792

5.  Inactivation of MuxABC-OpmB transporter system in Pseudomonas aeruginosa leads to increased ampicillin and carbenicillin resistance and decreased virulence.

Authors:  Liang Yang; Lin Chen; Lixin Shen; Michael Surette; Kangmin Duan
Journal:  J Microbiol       Date:  2011-03-03       Impact factor: 3.422

6.  Genetic analysis for virulence factors in Escherichia coli O104:H21 that was implicated in an outbreak of hemorrhagic colitis.

Authors:  P Feng; S D Weagant; S R Monday
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Prevalence and characterization of non-O157 shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States.

Authors:  Joseph M Bosilevac; Mohammad Koohmaraie
Journal:  Appl Environ Microbiol       Date:  2011-01-21       Impact factor: 4.792

8.  Colonization of the respiratory tract by a virulent strain of avian Escherichia coli requires carriage of a conjugative plasmid.

Authors:  C A Ginns; M L Benham; L M Adams; K G Whithear; K A Bettelheim; B S Crabb; G F Browning
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  Detection of hemolysin variants of Shiga toxin-producing Escherichia coli by PCR and culture on vancomycin-cefixime-cefsulodin blood agar.

Authors:  A Lehmacher; H Meier; S Aleksic; J Bockemühl
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792

10.  Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model.

Authors:  Peter C H Feng; Steven R Monday; David W Lacher; Lesley Allison; Anja Siitonen; Christine Keys; Marjut Eklund; Hideki Nagano; Helge Karch; James Keen; Thomas S Whittam
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.